MDAI

Spectral AI Inc

Add to Watchlist

Advanced Chart

2.440

+0.04(1.667%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

2.490

Open

2.400

VWAP

2.40

Vol

245.66K

Mkt Cap

62.82M

Low

2.370

Amount

588.74K

EV/EBITDA(TTM)

Total Shares

17.48M

47.98M

EV/OCF(TTM)

P/S(TTM)

1.59

Spectral AI, Inc. is a predictive artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. It is non-invasive, non-radiation, non-laser and does not require the use of injectable dye. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid healthcare providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

4.86M

-36.12%

5.13M

-37.19%

5.43M

-27.41%

Estimates Revision

The market is revising Upward the revenue expectations for Spectral AI, Inc. (MDAI) for FY2025, with the revenue forecasts being adjusted by 0.01% over the past three months. During the same period, the stock price has changed by 106.78%.

Revenue Estimates for FY2025

Revise Upward

+0.01%

In Past 3 Month

Stock Price

Go Up

+106.78%

In Past 3 Month

2 Analyst Rating

94.67% Upside

Wall Street analysts forecast MDAI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MDAI is 4.75 USD with a low forecast of 3.50 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

0 Hold

0 Sell

Moderate Buy

94.67% Upside

Current: 2.440

Low

3.50

Averages

4.75

High

6.00

94.67% Upside

Current: 2.440

Low

3.50

Averages

4.75

High

6.00

BTIG

Buy

downgrade

$3 -> $2

2025-05-14

Reason

BTIG

Price Target

$3 -> $2

2025-05-14

downgrade

Buy

Reason

BTIG lowered the firm's price target on Spectral AI to $2 from $3 and keeps a Buy rating on the shares after its Q1 results. The company is appropriately trimming operating spend to preserve cash, though the firm is reducing its price target to reflect a higher share count, the analyst tells investors in a research note. Spectral AI also continues to expect to submit DeepView to the FDA by the end of 2Q25 with approval expected in early FY26, the firm adds.

HC Wainwright & Co.

Swayampakula Ramakanth

Strong Buy

Reiterates

$3.5

2025-04-02

Reason

HC Wainwright & Co.

Swayampakula Ramakanth

Price Target

$3.5

2025-04-02

Reiterates

Strong Buy

Reason

HC Wainwright & Co.

Swayampakula Ramakanth

Strong Buy

Reiterates

$3.5

2025-03-18

Reason

HC Wainwright & Co.

Swayampakula Ramakanth

Price Target

$3.5

2025-03-18

Reiterates

Strong Buy

Reason

HC Wainwright & Co.

Swayampakula Ramakanth

Strong Buy

Reiterates

$3.5

2024-08-13

Reason

HC Wainwright & Co.

Swayampakula Ramakanth

Price Target

$3.5

2024-08-13

Reiterates

Strong Buy

Reason

Northland Capital Markets

Carl Byrnes

Buy

Initiates

2024-08-12

Reason

Northland Capital Markets

Carl Byrnes

Price Target

2024-08-12

Initiates

Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Spectral AI Inc (MDAI.O) is -9.11, compared to its 5-year average forward P/E of -1.66. For a more detailed relative valuation and DCF analysis to assess Spectral AI Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-1.66

Current PE

-9.11

Overvalued PE

0.56

Undervalued PE

-3.89

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-23.93

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.75

Undervalued EV/EBITDA

-48.62

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

6.56

Current PS

0.00

Overvalued PS

12.68

Undervalued PS

0.44